Research & Treatment

FOCUS AREA

Three-quarters of CAC2 member organizations fund essential research projects related to childhood and AYA cancer.

The Research and Treatment Interest Group strives to establish CAC2 as a credible resource for advancing the field of pediatric cancer research forward through thoughtful, progressive projects.

The Research and Treatment Interest Group’s remit is deep and broad: across the spectrum of development, from basic research through to clinical trials; across a wide range of topics, including data sharing, crucial medicines, psycho-social standards, and survivorship; and across the country and around the world.

Research funded by our members is crucial to discovering more effective treatments that minimize side effects and increase quality of life during and after treatment.

Most importantly, that research investment represents a shared aim to find cures for all types of childhood cancer. CAC2 celebrates each and every member’s efforts to help close the large and persistent gap between funding needs to achieve this goal and available resources.

CAC2 doesn’t just applaud our member’s individual efforts but strives to act as a catalyst for research members to work collaboratively to effect positive change in the childhood cancer research community.

The Research and Treatment Interest Group’s four-pronged strategy:

1

Hosting educational conferences and webinars across a multi-disciplinary childhood cancer research audience to encourage exchange of information and build relationships.

2

Providing the infrastructure and settings for member organizations to explore for co-funding research projects.

4

Establishing the Ethics Think Tank Working Group to help identify best practices and potential ethical issues associated with pediatric cancer charities that fund researchers and the relationships between those organizations and the research recipients.

“Talent wins games, but teamwork and intelligence win championships.” – Michael Jordan

Membership & Volunteer Participation

The Research and Treatment Interest Group strives to establish CAC2 as a credible resource for moving the field of pediatric cancer forward through thoughtful, progressive studies and projects.

Latest CAC2 Research News